Rapport Therapeutics Inc. (RAPP)
Market Closed
10 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
43. 46
-0.42
-0.9684%
Pre Market
$
+1.54 +3.5435% 45. 00
2.2B Market Cap
- P/E Ratio
- Div Yield
319,261 Volume
- Eps
$ 43.88
Previous Close 
Want to track RAPP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rapport Therapeutics Inc. (RAPP) Statistics
Valuation metrics
Market Cap 2.2B
Enterprise value 2.14B
Trailing P/E (ttm) -15.06
Forward P/E -
PEG ratio 0.7
Price/Sales (ttm) 109.45
Price/Book (mrq) 5.14
Enterprise Value/Revenue 106.78
Enterprise Value/EBITDA -14.42
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 279.9K
Average volume (90 days) 373.52K
Price summary
52-Week low 22.06
52-Week high 52.93
Beta -
50-Day moving average 44.52
200-Day moving average 34.81
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -6.86%
Operating margin -7.68%
Operational effectiveness
Return on assets -0.3%
Return on equity -0.29%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.42
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.89
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.19
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 15.72%
Book value per share (mrq) 8.91
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
